Product Parameters

Product Features

1. The surface of the product is activated by plasma treatment technology, and the chemical bonding between the surface layers forms a stable heparin coating: heparin surface treatment improves the biocompatibility of the product, and the literature on clinical applications shows that heparin surface treatment can reduce postoperative tissue reactions and cell desposition.
2. The design of the pre-loaded injection system meets the ergonomic requirments, with good controllability and more convenitent operation,and meets 2.2mm micro incision surgery, with small surgical astigmatism, quick recovery of postoperative vision, and improved postoperative visual quality.
3. The intraocular lens material has good biocompatibility and excellent homogeneity. Zero-impurity technology is adopted for the material polymerization. The nanometer numerical control processing technology and proprietary hydration cleaning technology are adopted for production and processing With high product purity and no glistening, there is no product turbidity and impurity deposition caused by material after the operation.
4. Negative aspheric aberration design trend, central zone spherical aberration design can accommodate surgical decentation and tilt to the maximum extent, peripheral zone spherical aberration design effectively compensate corneal spherical aberration; central zone and peripheral zone optical joint design retains proper depth of field, and reduce the total spherical aberration of human eyes after intraocular lens implantation, and improves visual quality comprehensively.
5. The intraocular lens is preloaded in the holder at the factory in standardization, so as to reduce the process of loading lenses during the operation compared with the traditional method, imporve the standardization operation level, avoid the failure of injection, and reduce the operation time. During the operation ,medical staffs do not need to touch the intraocular lens, which reduces the chance of process contamination and reduces the incidence of intraocular inflammation.

Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. was founded in 1991, is one of the first enterprises in China to produce intraocular lenses and related products. It has introduced advanced American technology and established a complete automated production line, integrating R&D, production, and sales. After 30 years of development, it has become China A benchmark enterprise in the field of intraocular lenses.

Till now, our company has products in sale, such as PMMA Intraocular Lens, Hydrophilic Acrylic Intraocular Lens, Glaucoma Drainage Implants, Hydroxypropyl Methylcellulose, Sodium Hyaluronate, Surgical Suture Needles with Thread, Disposal Injector for Foldable IOL and so on. Over 2 million Universe IOLs has been sold since their launch in 1991, with very low incidences of adverse effects and serious adverse events.

The highest eminence is to be gianed step by step.  Henan Universe Intraocular Lens Research and Manufacture Co., Ltd. will work hard and innovate constantly to improve the quantity of products, elevate the core competitiveness of the enterprise and make even greater contribution to the human health undertaking.